within Pharmacolibrary.Drugs.C_CardiovascularSystem.C01B_AntiarrhythmicsClassIAndIii.C01BB01_Lidocaine;
model Lidocaine 
   extends Pharmacolibrary.Drugs.ATC.C.C01BB01;

  annotation(Documentation(
    info ="<html><body><p>Lidocaine is a local anesthetic and antiarrhythmic drug that is primarily used to treat ventricular arrhythmias and to provide local or regional anesthesia. It is approved and widely used in clinical practice today for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported in healthy adult subjects following single intravenous bolus administration.</p><h4>References</h4><ol><li><p>Foong, KW, et al., &amp; Loh, PS (2024). Population Pharmacokinetics of Intravenous Lidocaine in Adults: A Systematic Review. <i>Clinical pharmacokinetics</i> 63(5) 623–643. DOI:<a href=&quot;https://doi.org/10.1007/s40262-024-01373-4&quot;>10.1007/s40262-024-01373-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38703307/&quot;>https://pubmed.ncbi.nlm.nih.gov/38703307</a></p></li><li><p>Beaussier, M, et al., &amp; Mercadal, L (2018). Perioperative Use of Intravenous Lidocaine. <i>Drugs</i> 78(12) 1229–1246. DOI:<a href=&quot;https://doi.org/10.1007/s40265-018-0955-x&quot;>10.1007/s40265-018-0955-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30117019/&quot;>https://pubmed.ncbi.nlm.nih.gov/30117019</a></p></li><li><p>Estebe, JP (2017). Intravenous lidocaine. <i>Best practice &amp; research. Clinical anaesthesiology</i> 31(4) 513–521. DOI:<a href=&quot;https://doi.org/10.1016/j.bpa.2017.05.005&quot;>10.1016/j.bpa.2017.05.005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29739540/&quot;>https://pubmed.ncbi.nlm.nih.gov/29739540</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Lidocaine;
